“Bridge over troubled water”OR “Road to nowhere”? Tune in for an update on blood purification therapies in sepsis by @GKlinkmann and the @KlinikumBS Nephro team. https://t.co/PzzbFyx4rM
🟠📣 We're officially 50 days away from the #42VicenzaCourse🎉
Get ready for an incredible journey of learning, networking, and innovation in the beautiful city of Vicenza 🇮🇹
Mark your calendars 🗓️ and stay tuned for updates 👉 https://t.co/Ltf5BSAdSr
Abstract deadline for ESAO-IFAO Congress August 29-September 1 in Bergamo has been extended to April 15. Accepted abstracts will be published in IJAO September issue. Submit your abstract on: https://t.co/mZVzcjs5fV
And now… what’s the best vasopressor for the kidney?
🔸 Be vary cautious between fluids and vasopressor
🔸 Vasopressin may be preferable to norepinephrine as a first-line vasopressor agent in the management vasoplegic shock after cardiac surgery
🔸 In septic and hemorrhagic shock, the potential benefit of vasopressin on renal function should continue to be tested
🔸 Renal effects of angiotensin II?
#ISICEM23 #FOAMcc
Register for the next ESAO-IFAO #Webinar on February 16th 2023, 12:00 PM CET with Prof. Marc Vila Cuenca and Prof. Paola Occhetta about "Human iPSC-derived 3D vessel-on-chip to model #Vascular disease and beyond"👇
https://t.co/P1QrxUEXYt
Recovery after AKI: Effects on outcomes over 15 years https://t.co/CILx8LnEun. It turns out that if you injury your kidney you'll loose life expectancy even if you appear to recover. Best not to develop AKI in the frist place @CCCNPitt@NephJC